Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sex Differences in the Dilatory Response of Compound 21

NCT05576155 is registered in ClinicalTrials.gov with Anna Stanhewicz, PhD as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05576155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sex Differences in the Dilatory Response of Compound 21
Lead sponsor
Anna Stanhewicz, PhD
Phase
Phase 1
Overall status
Completed
Start date
October 3, 2022
Completion date
February 23, 2023
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sex differences